Literature DB >> 12080379

Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery.

H Eliyahu1, N Servel, A J Domb, Y Barenholz.   

Abstract

We report a study aiming to characterize the interaction of blood and blood components with lipoplexes under conditions relevant to in vivo intravenous transfection. In this study we focus on the interaction of lipoplexes with red blood cells (RBC). It was found that no significant hemolysis occurred during several hours' incubation using lipoplex compositions and lipoplex/red blood cell ratios in the range commonly used for in vivo transfection. However, the interaction of RBC with lipoplexes resulted in massive agglutination, which occurs irrespective of the type of cationic lipid or helper lipid. Agglutination was also induced by polyplexes (such as dendrimer/DNA complexes) and lipoplexes in the presence of spermidine or protamine sulfate (the latter induced hemagglutination by itself). DSPE-PEG(2000) inserted into the lipoplexes inhibits hemagglutination somewhat. In order to understand the effect of serum on the agglutination better, plasma was separated into its high molecular weight components (HMWC, >14 kDa) and its low molecular weight components (LMWC, < or = 14 kDa). These fractions were characterized for their level of proteins, primary amino groups, osmotic pressure, and electrical conductivity, and compared with saline (0.15 M NaCl). It was found that both LMWC and HMWC inhibit agglutination by themselves, although whole serum demonstrates better hemagglutination inhibition than each fraction separately. The inhibitory effect of the serum (or plasma) is explained by its effect on the electrostatics of the lipoplexes, reducing their positive charge, as was demonstrated using fluorescein-phosphatidylethanolamine-labeled lipoplexes. The effect of LMWC was related to ionic strength and was equal to the effect of 0.15 M NaCl. The level of agglutination was reduced with increasing lipoplex DNA(-)/cationic lipid(+) (DNA(-)/L(+)) ratio. However, at the low DNA(-)/L(+) ratio needed to achieve significant in vivo transfection after i.v. administration, massive agglutination occurred. These data suggest that i.v. administration of lipoplexes and polyplexes may lead to RBC agglutination, and the agglutinates formed may explain the localization of lipoplexes and expression of their transgenes in the lungs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080379     DOI: 10.1038/sj.gt.3301705

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  19 in total

Review 1.  Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection.

Authors:  Crispin R Dass
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

2.  Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine.

Authors:  Xun Sun; Chester Provoda; Kyung-Dall Lee
Journal:  J Control Release       Date:  2010-07-07       Impact factor: 9.776

3.  Asymmetric 1-alkyl-2-acyl phosphatidylcholine: a helper lipid for enhanced non-viral gene delivery.

Authors:  Zhaohua Huang; Weijun Li; Francis C Szoka
Journal:  Int J Pharm       Date:  2011-06-21       Impact factor: 5.875

4.  Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.

Authors:  Yoshiyuki Hattori; Min Tang; Satomi Torii; Kana Tomita; Ayane Sagawa; Nodoka Inoue; Reo Yamagishi; Kei-Ichi Ozaki
Journal:  Mol Med Rep       Date:  2022-06-10       Impact factor: 3.423

5.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

Review 6.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

7.  Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer.

Authors:  Longzhu Piao; Hong Li; Lesheng Teng; Bryant C Yung; Yasuro Sugimoto; Robert W Brueggemeier; Robert J Lee
Journal:  Nanomedicine       Date:  2012-04-26       Impact factor: 5.307

8.  Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.

Authors:  Na Hyung Kim; Chester Provoda; Kyung-Dall Lee
Journal:  Mol Pharm       Date:  2015-01-22       Impact factor: 4.939

9.  Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia.

Authors:  Yoko Endo-Takahashi; Yoichi Negishi; Arisa Nakamura; Saori Ukai; Kotomi Ooaku; Yusuke Oda; Katsutoshi Sugimoto; Fuminori Moriyasu; Norio Takagi; Ryo Suzuki; Kazuo Maruyama; Yukihiko Aramaki
Journal:  Sci Rep       Date:  2014-01-24       Impact factor: 4.379

10.  Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.

Authors:  Yoshiyuki Hattori; Hiromu Saito; Teruaki Oku; Kei-Ichi Ozaki
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.